Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Advertising

This article was originally published in SRA

Executive Summary

Egypt cracks down on advertisements for unregistered drugs

Egypt cracks down on advertisements for unregistered drugs

The Egyptian minister of health, Hatem El-Gabaly, has filed a complaint with the country's general prosecutor regarding the advertising of unregistered pharmaceutical products in newspapers and various other media (radio and television)1. In his complaint Professor El-Gabaly explained that these advertisements publicise unregistered pharmaceutical products with unproven medical claims and that these advertisements usually use sexually explicit material and improper language to attract patients. He also described the potential health hazards that these advertisements can cause, saying that the products in question (generally for the treatment of sexual disorders and weight control) might cause serious side effects and most probably would have none of the claimed medical benefits.

In response to this complaint, the general prosecutor has sent an official letter to the Egyptian Syndicate of Journalists, the High Committee of Journalism, the Ministry of Information, the Ministry of Commerce and the Consumer Protection Regulatory Agency, which requires that all these bodies co-operate in preventing such advertisements and seek to enforce the Pharmacy Law (127/1955).This states that: when advertising a pharmaceutical product, the advertisement must contain claims that have been revised and approved by the Ministry of Health during the registration procedures of the product. The advertisement must be in ethical language and must not contain any material that might lure the public or be against common moral principles … any medical advertisement must first be approved by the Pharmaceutical High Technical Committee before being published in any Egyptian media.

Background

In the last few years many private newspapers have emerged in Egypt. The commercial business of unregistered “cocktails” and herbal products with unproven medical claims has also boomed recently. These products are mainly for the treatment of sexual disorders, such as impotence, and weight control. These newspapers, under the economic temptation of publishing various ads for unregistered pharmaceutical products, have overlooked the law regulating such advertisements. With the great increase in the number of these newspapers, monitoring every advertisement has become a challenge.

Although the government-sponsored newspapers (eg Al-Ahram newspaper) and television channels strictly enforce the Pharmacy Law, the general prosecutor is aiming to control the illegal ads that have appeared in the other media. In addition, Professor El-Gabaly has established a new committee led by Hamdi El-Sayed, the head of the Egyptian Medical Syndicate (representing physicians), and including the head of the Pharmacists' Syndicate, Zakaria Gad, to discuss possible ways of monitoring these ads and preventing them. Professor El-Gabaly has also published in the government-sponsored newspapers warnings to the public not to believe such ads and not to use any of the advertised products, especially those sold outside the officially registered pharmacies (eg by mail order).

GIHAN TAHA

References

1. Al-Ahram newspaper, 12 March 2007

Latest Headlines
See All
UsernamePublicRestriction

Register

PS111831

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel